Welcome to our dedicated page for GSAH news (Ticker: GSAH), a resource for investors and traders seeking the latest updates and insights on GSAH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GSAH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GSAH's position in the market.
Mirion Technologies (NYSE: MIR) has commenced trading on the New York Stock Exchange following its successful business combination with GS Acquisition Holdings Corp II. The company's Class A common stock and warrants are now trading under the symbols 'MIR' and 'MIRW'. With a fiscal year 2021 revenue of $612 million, reflecting a growth of 27.9% year-over-year, Mirion aims to expand its product offerings in industrial technology and medical sectors. CEO Thomas Logan anticipates continued growth and welcomes Larry Kingsley as Chairman to lead strategic initiatives.
Mirion Technologies, Inc. has successfully completed its business combination with GS Acquisition Holdings Corp II (GSAH), approved by GSAH stockholders on October 19, 2021. Following this merger, GSAH has rebranded as Mirion and will commence trading on the New York Stock Exchange under the ticker symbols 'MIR' and 'MIRW' on October 21, 2021. The transaction raised approximately $604 million in trust proceeds and an additional $900 million from a private placement, which will assist in driving growth and product innovation in the nuclear, defense, and medical markets.
GS Acquisition Holdings Corp II (GSAH) announced a significant upward revision of trust proceeds to
GS Acquisition Holdings Corp II (GSAH) announced that its stockholders approved the business combination with Mirion Technologies, Inc., paving the way for the transaction's closing around October 20, 2021. Post-closure, the merged entity will operate under the name Mirion Technologies, with its Class A common stock and warrants trading under the new ticker symbols ‘MIR’ and ‘MIRW’ on the New York Stock Exchange. Stockholders can withdraw redemption requests until October 19, 2021, at 5:00 p.m. Eastern Time.
GS Acquisition Holdings Corp II (NYSE: GSAH) is set to complete its business combination with Mirion Technologies, pending stockholder approval. A Special Meeting is scheduled for October 19, 2021, with the anticipated close on October 20, 2021. The deal is expected to raise approximately $2.3 billion, with $554 million from trust proceeds, $900 million from a PIPE, and $830 million from loan financing. Mirion, a leader in radiation detection technologies, will receive $1.3 billion to pay existing stockholders and refinance debt.
Mirion Technologies has announced that it has received all regulatory approvals for its upcoming business combination with GS Acquisition Holdings Corp II (GSAH). Approvals were granted by regulatory organizations in Finland, France, and Germany. The merger is expected to close on October 20, 2021, pending stockholder approval. GSAH's stockholder meeting is set for October 19, 2021, at 10:00 am ET. This combination is aimed at enhancing Mirion's positioning within the detection, measurement, and monitoring solutions sectors.
Mirion Technologies, Inc. has announced the acquisition of the Dosimetry Badge brand, a US-based distributor of personal dosimeter badges, enhancing its footprint in the US dosimetry market. Dosimetry Badge recorded nearly $500,000 in revenue in 2020, serving over 2,000 customers across various industries. This acquisition is expected to strengthen Mirion's dosimetry operations and provide existing customers with broader options. Additionally, Mirion anticipates completing its business combination with GS Acquisition Holdings Corp II (GSAH) in the second half of 2021, pending regulatory approvals.
GS Acquisition Holdings Corp II (NYSE: GSAH) has filed a definitive proxy statement with the SEC regarding its proposed business combination with Mirion Technologies. A special meeting for GSAH shareholders is scheduled for October 19, 2021, to approve the merger, which is expected to close on October 21, 2021, pending closing conditions. The merger aims to make Mirion a public company, enhancing its growth potential and financial performance in radiation detection and measurement technologies.
Mirion Technologies, Inc. has announced nominees for its Board of Directors following its planned merger with GSA Acquisition Holdings Corp II (GSAH). The nominees, comprising experienced leaders from various sectors, include Thomas D. Logan, who has been CEO since 2005, and Lawrence D. Kingsley, former CEO of Pall Corporation. The business combination, expected to complete in H2 2021, will make Mirion a publicly listed company. This strategic shift may enhance its market position, benefiting its operational capabilities in nuclear and defense sectors.
Mirion Technologies has launched its new Apex-Guard software, enhancing data security and compliance for pharmaceutical customers under FDA regulations. Key features include role-based security, digital signatures, and improved audit logs. The software operates on a subscription model, ensuring customers remain compliant with updates. This launch complements Mirion's existing Apex-Gamma™ Lab Productivity Suite. Mirion also plans to go public through a merger with GS Acquisition Holdings Corp II (NYSE: GSAH) in the second half of 2021, pending regulatory approvals.
